In this study, we provide the first evidence using isogenic iPSCs derived from a heterozygous female RTT patient that a loss of function MeCP2 mutation can directly alter the electrophysiological properties of human cardiomyocytes. This evidence concerns the gene MECP2 and Rett syndrome.